Is deferred use of bevacizumab for glioblastoma associated with prolonged survival?

Neuro Oncol. 2014 Oct;16(10):1427. doi: 10.1093/neuonc/nou150. Epub 2014 Jul 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Brain Neoplasms / drug therapy*
  • Female
  • Glioblastoma / drug therapy*
  • Humans
  • Male
  • Neoplasm Recurrence, Local / drug therapy*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized